Citius Pharmaceuticals (CTXR) Selling, General & Administrative (2010 - 2026)
Citius Pharmaceuticals (CTXR) posted Selling, General & Administrative of $6.15 million for fiscal Q3 2026 (quarter ended Jun 30, 2026), up 38.3% from $4.45 million a year earlier but down 76.7% from the prior quarter.
Citius Pharmaceuticals (CTXR) Selling, General & Administrative (2010 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Selling, General & Administrative at Citius Pharmaceuticals was $42.17 million, up 109.6% year-over-year; for FY2025 (ended Sep 30, 2025), it was $18.53 million, up 1.6% from FY2024.
- Annual Selling, General & Administrative has increased for six consecutive fiscal years, with a five-year compound annual growth rate of 18.0% (FY2020 to FY2025).
- In prior fiscal years, Citius Pharmaceuticals' Selling, General & Administrative was $18.25 million in FY2024 (+19.3%), $15.3 million in FY2023 (+30.1%), $11.75 million in FY2022 (+19.5%) and $9.84 million in FY2021 (+21.5%).
- Quarterly Selling, General & Administrative has run from a low of $2.45 million in fiscal Q4 2021 to a high of $26.39 million in fiscal Q2 2026 over five years.
- On a year-over-year basis, Selling, General & Administrative has increased in each of the last three quarters, with growth averaging 68.7% over the last eight quarters.
- The strongest year-over-year quarter for Selling, General & Administrative in the past five years was fiscal Q2 2026, with growth of 450.7%; the weakest was fiscal Q4 2025, with a decline of 28.9%.
- According to Business Quant data, Selling, General & Administrative for the three prior fiscal quarters was $26.39 million (Q2 2026), $5.72 million (Q1 2026) and $3.91 million (Q4 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 3.43 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 6.43 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 3.63 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 2.90 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | -3.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | -5.65 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 1.75 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 1.92 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 3.41 Bn |
| 10 | Citius Pharmaceuticals | 14.55 Mn | 23.85 Mn | 1.00 Mn | 6.15 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 6.15 Mn |
| Mar 31, 2026 | 26.39 Mn |
| Dec 31, 2025 | 5.72 Mn |
| Sep 30, 2025 | 3.91 Mn |
| Jun 30, 2025 | 4.45 Mn |
| Mar 31, 2025 | 4.79 Mn |
| Dec 31, 2024 | 5.39 Mn |
| Sep 30, 2024 | 5.49 Mn |
| Jun 30, 2024 | 4.81 Mn |
| Mar 31, 2024 | 4.29 Mn |
| Dec 31, 2023 | 3.66 Mn |
| Sep 30, 2023 | 4.17 Mn |
| Jun 30, 2023 | 3.73 Mn |
| Mar 31, 2023 | 4.79 Mn |
| Dec 31, 2022 | 2.60 Mn |
| Sep 30, 2022 | 2.72 Mn |
| Jun 30, 2022 | 3.02 Mn |
| Mar 31, 2022 | 3.12 Mn |
| Dec 31, 2021 | 2.90 Mn |
| Sep 30, 2021 | 2.45 Mn |
Citius Pharmaceuticals Selling, General & Administrative API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=CTXR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "selling-general-and-administrative", "ticker": "CTXR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=CTXR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();